Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 907

1.

Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANT.

Abdul-Rahim AH, Docherty KF, Skali H, Køber L, Dickstein K, Maggioni AP, Mareev V, Zannad F, Velazquez EJ, Califf RM, Pfeffer MA, Solomon SD, Lees KR, McMurray JJ.

Eur Stroke J. 2016 Jun;1(2):93-100. doi: 10.1177/2396987316646025. Epub 2016 May 9.

PMID:
31008270
2.

Cohort profile The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry.

Habib G, Lancellotti P, Erba PA, Sadeghpour A, Meshaal M, Sambola A, Furnaz S, Citro R, Ternacle J, Donal E, Cosyns B, Popescu B, Iung B, Prendergast B, Laroche C, Tornos P, Pazdernik M, Maggioni A, Gale CP; EURO-ENDO Investigators.

Eur Heart J Qual Care Clin Outcomes. 2019 Apr 8. pii: qcz018. doi: 10.1093/ehjqcco/qcz018. [Epub ahead of print]

PMID:
30957862
3.

Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC).

Roos-Hesselink J, Baris L, Johnson M, De Backer J, Otto C, Marelli A, Jondeau G, Budts W, Grewal J, Sliwa K, Parsonage W, Maggioni AP, van Hagen I, Vahanian A, Tavazzi L, Elkayam U, Boersma E, Hall R.

Eur Heart J. 2019 Mar 25. pii: ehz136. doi: 10.1093/eurheartj/ehz136. [Epub ahead of print]

PMID:
30907409
4.

Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry.

Boriani G, Proietti M, Laroche C, Fauchier L, Marin F, Nabauer M, Potpara T, Dan GA, Kalarus Z, Tavazzi L, Maggioni AP, Lip GYH; EORP-AF Long-Term General Registry Investigators.

Europace. 2019 Mar 24. pii: euz032. doi: 10.1093/europace/euz032. [Epub ahead of print]

PMID:
30904925
5.

Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.

Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Alexander KP, Senior R, Boden WE, Stone GW, Goodman SG, Lopes RD, Lopez-Sendon J, White HD, Maggioni AP, Shaw LJ, Min JK, Picard MH, Berman DS, Chaitman BR, Mark DB, Spertus JA, Cyr DD, Bhargava B, Ruzyllo W, Wander GS, Chernyavskiy AM, Rosenberg YD, Maron DJ; ISCHEMIA Research Group.

JAMA Cardiol. 2019 Feb 27. doi: 10.1001/jamacardio.2019.0014. [Epub ahead of print]

PMID:
30810700
6.

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry.

Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee D, Maggioni A, Marques-Vidal P, Jennings C, Abreu A, Aguiar C, Badariene J, Bruthans J, Castro Conde A, Cifkova R, Crowley J, Davletov K, Deckers J, De Smedt D, De Sutter J, Dilic M, Dolzhenko M, Dzerve V, Erglis A, Fras Z, Gaita D, Gotcheva N, Heuschmann P, Hasan-Ali H, Jankowski P, Lalic N, Lehto S, Lovic D, Mancas S, Mellbin L, Milicic D, Mirrakhimov E, Oganov R, Pogosova N, Reiner Z, Stöerk S, Tokgözoğlu L, Tsioufis C, Vulic D, Wood D; EUROASPIRE Investigators*.

Eur J Prev Cardiol. 2019 Feb 10:2047487318825350. doi: 10.1177/2047487318825350. [Epub ahead of print]

7.

Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials.

Cholesterol Treatment Trialists' Collaboration.

Lancet. 2019 Feb 2;393(10170):407-415. doi: 10.1016/S0140-6736(18)31942-1.

8.

Stroke Outcomes in the COMPASS Trial.

Sharma M, Hart RG, Connolly SJ, Bosch J, Shestakovska O, Ng KKH, Catanese L, Keltai K, Aboyans V, Alings M, Ha JW, Varigos J, Tonkin A, O'Donnell M, Bhatt DL, Fox K, Maggioni A, Berkowitz SD, Bruns NC, Yusuf S, Eikelboom JW.

Circulation. 2019 Feb 26;139(9):1134-1145. doi: 10.1161/CIRCULATIONAHA.118.035864.

PMID:
30667279
9.

Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.

Ozierański K, Balsam P, Kapłon-Cieślicka A, Tymińska A, Kowalik R, Grabowski M, Peller M, Wancerz A, Marchel M, Crespo-Leiro MG, Maggioni AP, Drożdż J, Filipiak KJ, Opolski G.

Cardiovasc Drugs Ther. 2019 Feb;33(1):77-86. doi: 10.1007/s10557-018-6843-5.

PMID:
30649675
10.

Differences in clinical characteristics and 1-year outcomes of hospitalized patients with heart failure in ESC-HF Pilot and ESC-HF-LT registries.

Balsam P, Ozierański K, Kapłon-Cieślicka A, Borodzicz S, Tymińska A, Peller M, Marchel M, Crespo-Leiro MG, Maggioni AP, Drożdż J, Opolski G, Grabowski M.

Pol Arch Intern Med. 2019 Feb 28;129(2):106-116. doi: 10.20452/pamw.4418. Epub 2019 Jan 16.

11.

Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration.

Seferovic JP, Bentley-Lewis R, Claggett B, Diaz R, Gerstein HC, Køber LV, Lawson FC, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, Pfeffer MA.

J Diabetes Res. 2018 Dec 16;2018:1631263. doi: 10.1155/2018/1631263. eCollection 2018.

12.

Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years.

Paolillo S, Veglia F, Salvioni E, Corrà U, Piepoli M, Lagioia R, Limongelli G, Sinagra G, Cattadori G, Scardovi AB, Metra M, Senni M, Bonomi A, Scrutinio D, Raimondo R, Emdin M, Magrì D, Parati G, Re F, Cicoira M, Minà C, Correale M, Frigerio M, Bussotti M, Battaia E, Guazzi M, Badagliacca R, Di Lenarda A, Maggioni A, Passino C, Sciomer S, Pacileo G, Mapelli M, Vignati C, Clemenza F, Binno S, Lombardi C, Filardi PP, Agostoni P; MECKI Score Research Group (see Appendix).

Eur J Heart Fail. 2019 Feb;21(2):208-217. doi: 10.1002/ejhf.1364. Epub 2019 Jan 11.

PMID:
30632680
13.

Atrial fibrillation history impact on catheter ablation outcome. Findings from the ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry.

Stabile G, Trines SA, Arbelo E, Dagres N, Brugada J, Kautzner J, Pokushalov E, Maggioni AP, Laroche C, Anselmino M, Beinart R, Traykov V, Blomström Lundqvist C; ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry investigators.

Pacing Clin Electrophysiol. 2019 Mar;42(3):313-320. doi: 10.1111/pace.13600. Epub 2019 Jan 22.

PMID:
30632196
14.

Procedural outcomes associated with transvenous lead extraction in patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) Registry Sub-Analysis.

Segreti L, Rinaldi CA, Claridge S, Svendsen JH, Blomstrom-Lundqvist C, Auricchio A, Butter C, Dagres N, Deharo JC, Maggioni AP, Kutarski A, Kennergren C, Laroche C, Kempa M, Magnani A, Casteigt B, Bongiorni MG; ELECTRa Investigators.

Europace. 2019 Apr 1;21(4):645-654. doi: 10.1093/europace/euy307.

PMID:
30624715
15.

Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX-AHF-EU.

Maggioni AP, López-Sendón J, Nielsen OW, Hallén J, Aalamian-Mattheis M, Wang Y, Ertl G.

Eur J Heart Fail. 2019 Mar;21(3):322-333. doi: 10.1002/ejhf.1368. Epub 2019 Jan 2.

PMID:
30604559
16.

Major cardiac and vascular complications after transvenous lead extraction: acute outcome and predictive factors from the ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) registry.

Zucchelli G, Di Cori A, Segreti L, Laroche C, Blomstrom-Lundqvist C, Kutarski A, Regoli F, Butter C, Defaye P, Pasquié JL, Auricchio A, Maggioni AP, Bongiorni MG.

Europace. 2018 Dec 27. doi: 10.1093/europace/euy300. [Epub ahead of print]

PMID:
30590520
17.

Modes of death and prognostic outliers in chronic heart failure.

Canepa M, Ameri P, Lucci D, Nicolosi GL, Marchioli R, Porcu M, Tognoni G, Franzosi MG, Latini R, Maseri A, Tavazzi L, Maggioni AP; GISSI-HF Investigators.

Am Heart J. 2019 Feb;208:100-109. doi: 10.1016/j.ahj.2018.11.009. Epub 2018 Nov 24.

PMID:
30580128
18.

[When a purely observational approach does not provide reliable evidence].

Gulizia MM, Maggioni AP.

G Ital Cardiol (Rome). 2018 Dec;19(12):727-728. doi: 10.1714/3027.30258. Italian. No abstract available.

PMID:
30520889
19.

Audits of clinical practice should be encouraged. Use of loop diuretics in patients without a diagnosis of heart failure should be discouraged.

Maggioni AP.

Eur J Prev Cardiol. 2019 Feb;26(3):289-290. doi: 10.1177/2047487318817075. Epub 2018 Dec 3. No abstract available.

PMID:
30509145
20.

Patterns of treatment with antiplatelet therapy after an acute coronary syndrome: Data from a large database in a community setting.

Cimminiello C, Dondi L, Pedrini A, Ronconi G, Calabria S, Piccinni C, Polo Friz H, Martini N, Maggioni AP.

Eur J Prev Cardiol. 2018 Nov 26:2047487318814970. doi: 10.1177/2047487318814970. [Epub ahead of print]

PMID:
30477319

Supplemental Content

Loading ...
Support Center